123 related articles for article (PubMed ID: 35093875)
1. The Natural Estrogen Receptor Beta Agonist Silibinin as a Promising Therapeutic Tool in Diffuse Large B-cell Lymphoma.
Ortona E; Locatelli SL; Pagano MT; Ascione B; Careddu G; Dupuis ML; Marconi M; Carlo-Stella C; Malorni W; Matarrese P; Pierdominici M
Anticancer Res; 2022 Feb; 42(2):767-779. PubMed ID: 35093875
[TBL] [Abstract][Full Text] [Related]
2. The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis.
Dupuis ML; Conti F; Maselli A; Pagano MT; Ruggieri A; Anticoli S; Fragale A; Gabriele L; Gagliardi MC; Sanchez M; Ceccarelli F; Alessandri C; Valesini G; Ortona E; Pierdominici M
Front Immunol; 2018; 9():1903. PubMed ID: 30174672
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptors participate in silibinin-caused nuclear translocation of apoptosis-inducing factor in human breast cancer MCF-7 cells.
Liu W; Ji Y; Sun Y; Si L; Fu J; Hayashi T; Onodera S; Ikejima T
Arch Biochem Biophys; 2020 Aug; 689():108458. PubMed ID: 32524997
[TBL] [Abstract][Full Text] [Related]
4. The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagy.
Liu H; Wei J; Sang N; Zhong X; Zhou X; Yang X; Zhang J; Zuo Z; Zhou Y; Yang S; Du J; Zhao Y
Med Oncol; 2021 Sep; 38(10):124. PubMed ID: 34491469
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor β ligation inhibits Hodgkin lymphoma growth by inducing autophagy.
Pierdominici M; Maselli A; Locatelli SL; Ciarlo L; Careddu G; Patrizio M; Ascione B; Tinari A; Carlo-Stella C; Malorni W; Matarrese P; Ortona E
Oncotarget; 2017 Jan; 8(5):8522-8535. PubMed ID: 28052027
[TBL] [Abstract][Full Text] [Related]
6. Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation.
Shi Z; Zhou Q; Gao S; Li W; Li X; Liu Z; Jin P; Jiang J
Life Sci; 2019 Jan; 217():70-80. PubMed ID: 30452972
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk of ROS/RNS and autophagy in silibinin-induced apoptosis of MCF-7 human breast cancer cells in vitro.
Zheng N; Liu L; Liu WW; Li F; Hayashi T; Tashiro SI; Onodera S; Ikejima T
Acta Pharmacol Sin; 2017 Feb; 38(2):277-289. PubMed ID: 27867187
[TBL] [Abstract][Full Text] [Related]
8. The Anticancer Properties of Silibinin: Its Molecular Mechanism and Therapeutic Effect in Breast Cancer.
Binienda A; Ziolkowska S; Pluciennik E
Anticancer Agents Med Chem; 2020; 20(15):1787-1796. PubMed ID: 31858905
[TBL] [Abstract][Full Text] [Related]
9. Dracocephalum palmatum Stephan extract induces caspase‑ and mitochondria‑dependent apoptosis via Myc inhibition in diffuse large B cell lymphoma.
Kim J; Kim JN; Park I; Sivtseva S; Okhlopkova Z; Zulfugarov IS; Kim SW
Oncol Rep; 2020 Dec; 44(6):2746-2756. PubMed ID: 33125144
[TBL] [Abstract][Full Text] [Related]
10. Silibinin inhibited autophagy and mitochondrial apoptosis in pancreatic carcinoma by activating JNK/SAPK signaling.
Zhang X; Jiang J; Chen Z; Cao M
Pathol Res Pract; 2019 Sep; 215(9):152530. PubMed ID: 31351801
[TBL] [Abstract][Full Text] [Related]
11. β-Elemene suppresses tumor growth of diffuse large B-cell lymphoma through regulating lncRNA HULC-mediated apoptotic pathway.
Hu T; Gao Y
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32010942
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model.
Yang CY; Tsao CH; Hsieh CC; Lin CK; Lin CS; Li YH; Chang WC; Cheng JC; Lin GJ; Sytwu HK; Wang YL; Chen YW
PLoS One; 2020; 15(7):e0236101. PubMed ID: 32678829
[TBL] [Abstract][Full Text] [Related]
13. Induction of autophagy and autophagy-dependent apoptosis in diffuse large B-cell lymphoma by a new antimalarial artemisinin derivative, SM1044.
Cheng C; Wang T; Song Z; Peng L; Gao M; Hermine O; Rousseaux S; Khochbin S; Mi JQ; Wang J
Cancer Med; 2018 Feb; 7(2):380-396. PubMed ID: 29277967
[TBL] [Abstract][Full Text] [Related]
14. Anti-Tumor Activity and Mechanism of Silibinin Based on Network Pharmacology and Experimental Verification.
Li P; Wang D; Yang X; Liu C; Li X; Zhang X; Liu K; Zhang Y; Zhang M; Wang C; Wang R
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675723
[TBL] [Abstract][Full Text] [Related]
15. Silibinin promotes the apoptosis of gastric cancer BGC823 cells through caspase pathway.
Li R; Yu J; Wang C
J BUON; 2017; 22(5):1148-1153. PubMed ID: 29135096
[TBL] [Abstract][Full Text] [Related]
16. Targeting the hallmarks of cancer: the effects of silibinin on proliferation, cell death, angiogenesis, and migration in colorectal cancer.
Sameri S; Mohammadi C; Mehrabani M; Najafi R
BMC Complement Med Ther; 2021 May; 21(1):160. PubMed ID: 34059044
[TBL] [Abstract][Full Text] [Related]
17. Silibinin, A Natural Blend In Polytherapy Formulation For Targeting Cd44v6 Expressing Colon Cancer Stem Cells.
Patel S; Waghela B; Shah K; Vaidya F; Mirza S; Patel S; Pathak C; Rawal R
Sci Rep; 2018 Nov; 8(1):16985. PubMed ID: 30451890
[TBL] [Abstract][Full Text] [Related]
18. Functionalized Caprolactone-Polyethylene Glycol Based Thermo-Responsive Hydrogels of Silibinin for the Treatment of Malignant Melanoma.
Makhmalzadeh BS; Molavi O; Vakili MR; Zhang HF; Solimani A; Abyaneh HS; Loebenberg R; Lai R; Lavasanifar A
J Pharm Pharm Sci; 2018; 21(1):143-159. PubMed ID: 29789104
[TBL] [Abstract][Full Text] [Related]
19. The tumor suppressive role of inhibin βA in diffuse large B-cell lymphoma.
Jiang L; Si T; Yu M; Zeng X; Morse HC; Lu Y; Ouyang G; Zhou JX
Leuk Lymphoma; 2018 May; 59(5):1202-1212. PubMed ID: 28877610
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of anti-cancer potency of silibinin on murine renal carcinoma RenCa cells in an animal model with an intact immune system.
Yang C; Li F; Ma J; Zhang HB; Jia J; Zeng J; Wang X; He D; Guo P
Anticancer Drugs; 2020 Sep; 31(8):785-791. PubMed ID: 32209841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
